Volume 85, Issue 5, Pages (May 2014)

Slides:

Advertisements

Similar presentations

Anemia management in chronic kidney disease

Advertisements

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 83, Issue 3, Pages (March 2013)

Volume 87, Issue 1, Pages (January 2015)

Robert W. Schrier, Kimberly K. McFann, Ann M. Johnson

Volume 86, Issue 6, Pages (December 2014)

Kidney transplantation in a low-resource setting: Nigeria experience

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Burden of chronic kidney disease: North Africa

Volume 80, Issue 4, Pages (August 2011)

Skin Biopsy Is a Practical Approach for the Clinical Diagnosis and Molecular Genetic Analysis of X-Linked Alport's Syndrome Fang Wang, Dan Zhao, Jie.

Volume 87, Issue 1, Pages (January 2015)

Volume 86, Issue 6, Pages (December 2014)

End-stage renal disease in living kidney donors

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 79, Issue 1, Pages (January 2011)

Comorbidity and confounding in end-stage renal disease

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

Volume 74, Issue 3, Pages (August 2008)

Lipid redistribution in renal dysfunction

Volume 70, Issue 11, Pages (December 2006)

Manjula Kurella Tamura, Kristine Yaffe Kidney International

The Case ∣ A young man with acute kidney injury after exercise

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Volume 73, Issue 10, Pages (May 2008)

Volume 73, Issue 12, Pages (June 2008)

Volume 76, Issue 6, Pages (September 2009)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Alternate-day dialysis may be needed for hemodialysis patients

Racial disparities in access to transplantation: a tough nut to crack

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Volume 73, Issue 7, Pages (April 2008)

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 74, Issue 5, Pages (September 2008)

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Unilateral renal cystic disease

Volume 81, Issue 9, Pages (May 2012)

Volume 86, Issue 4, Pages (October 2014)

Prehypertension: is it relevant for nephrologists?

Homocysteine, renal function, and risk of cardiovascular disease

Volume 73, Issue 9, Pages (May 2008)

Alport syndrome: Is diagnosis only skin-deep?

Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass

Low triiodothyronine and survival in end-stage renal disease

The Iranian model of living renal transplantation

Volume 80, Issue 10, Pages (November 2011)

Volume 67, Issue 4, Pages (April 2005)

Volume 85, Issue 6, Pages (June 2014)

ANCA comes of age—but with caveats

Volume 75, Issue 7, Pages (April 2009)

Membranous nephropathy: recent travels and new roads ahead

More women are affected than men in X-linked Alport syndrome.

Volume 72, Issue 11, Pages (December 2007)

Patrick S. Parfrey, William S. Davidson, Jane S. Green

The international realities of live donor kidney transplantation

Volume 70, Issue 10, Pages (November 2006)

Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

The risk of siblings being affected depends on the mode of inheritance and the gender of the affected parent (in X-linked disease). The risk of siblings.

Volume 67, Issue 4, Pages (April 2005)

The Ebf1 knockout mouse and glomerular maturation

Presentation transcript:

Volume 85, Issue 5, Pages 1208-1213 (May 2014) Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain Yuya Hashimura, Kandai Nozu, Hiroshi Kaito, Koichi Nakanishi, Xue Jun Fu, Hiromi Ohtsubo, Fusako Hashimoto, Masafumi Oka, Takeshi Ninchoji, Shingo Ishimori, Naoya Morisada, Natsuki Matsunoshita, Naohiro Kamiyoshi, Norishige Yoshikawa, Kazumoto Iijima Kidney International Volume 85, Issue 5, Pages 1208-1213 (May 2014) DOI: 10.1038/ki.2013.479 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Flow diagram showing patient recruitment and analysis. Fifty-two proven XLAS males were finally enrolled in this study. AS, Alport syndrome; XLAS, AS patients showing X-linked inheritance. Kidney International 2014 85, 1208-1213DOI: (10.1038/ki.2013.479) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Distribution map of COL4A5 missense mutations. Black circles define the positions of missense mutations in the negative group, and open circles show the positions of missense mutations in the positive group. Kidney International 2014 85, 1208-1213DOI: (10.1038/ki.2013.479) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 3 Age at onset of end-stage renal disease (ESRD) in negative (n=14) and positive group (n=15) patients and their affected male family members. The onset age was significantly lower in negative group compared with positive group patients (24.00±14.2 and 37.53±16.30 years, respectively; P=0.018). Kidney International 2014 85, 1208-1213DOI: (10.1038/ki.2013.479) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 4 Probability of hearing loss in the type IV collagen α5 (α5(IV))-positive and -negative groups. The median age for developing hearing loss was 13 years in the negative group, whereas no patients in the positive group developed hearing loss. Kidney International 2014 85, 1208-1213DOI: (10.1038/ki.2013.479) Copyright © 2014 International Society of Nephrology Terms and Conditions